141 related articles for article (PubMed ID: 24013743)
41. Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling.
Fleck D; van Bebber F; Colombo A; Galante C; Schwenk BM; Rabe L; Hampel H; Novak B; Kremmer E; Tahirovic S; Edbauer D; Lichtenthaler SF; Schmid B; Willem M; Haass C
J Neurosci; 2013 May; 33(18):7856-69. PubMed ID: 23637177
[TBL] [Abstract][Full Text] [Related]
42. The non-amyloidogenic pathway: structure and function of alpha-secretases.
Kojro E; Fahrenholz F
Subcell Biochem; 2005; 38():105-27. PubMed ID: 15709475
[TBL] [Abstract][Full Text] [Related]
43. ADAM proteases: protective role in Alzheimer's and prion diseases?
Vincent B
Curr Alzheimer Res; 2004 Aug; 1(3):165-74. PubMed ID: 15975064
[TBL] [Abstract][Full Text] [Related]
44. Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
Vincent B; Cisse MA; Sunyach C; Guillot-Sestier MV; Checler F
Curr Alzheimer Res; 2008 Apr; 5(2):202-11. PubMed ID: 18393805
[TBL] [Abstract][Full Text] [Related]
45. Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain.
Gil-Bea F; Akterin S; Persson T; Mateos L; Sandebring A; Avila-Cariño J; Gutierrez-Rodriguez A; Sundström E; Holmgren A; Winblad B; Cedazo-Minguez A
EMBO Mol Med; 2012 Oct; 4(10):1097-111. PubMed ID: 22933306
[TBL] [Abstract][Full Text] [Related]
46. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells.
Nord LC; Sundqvist J; Andersson E; Fried G
Neurodegener Dis; 2010; 7(6):349-64. PubMed ID: 20523023
[TBL] [Abstract][Full Text] [Related]
47. Identification and mutagenesis of the TACE and γ-secretase cleavage sites in the colony-stimulating factor 1 receptor.
Vahidi A; Glenn G; van der Geer P
Biochem Biophys Res Commun; 2014 Jul; 450(1):782-7. PubMed ID: 24955855
[TBL] [Abstract][Full Text] [Related]
48. Knock-down of protein L-isoaspartyl O-methyltransferase increases β-amyloid production by decreasing ADAM10 and ADAM17 levels.
Bae N; Byeon SE; Song J; Lee SJ; Kwon M; Mook-Jung I; Cho JY; Hong S
Acta Pharmacol Sin; 2011 Mar; 32(3):288-94. PubMed ID: 21372823
[TBL] [Abstract][Full Text] [Related]
49. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
50. A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis.
Andrew RJ; Kellett KA; Thinakaran G; Hooper NM
J Biol Chem; 2016 Sep; 291(37):19235-44. PubMed ID: 27474742
[TBL] [Abstract][Full Text] [Related]
51. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
52. A crucial role for the phosphorylation of STRAP at Ser(188) by MPK38 in STRAP-dependent cell death through ASK1, TGF-β, p53, and PI3K/PDK1 signaling pathways.
Seong HA; Manoharan R; Ha H
Cell Cycle; 2014; 13(21):3357-74. PubMed ID: 25485581
[TBL] [Abstract][Full Text] [Related]
53. An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function.
Schlepckow K; Kleinberger G; Fukumori A; Feederle R; Lichtenthaler SF; Steiner H; Haass C
EMBO Mol Med; 2017 Oct; 9(10):1356-1365. PubMed ID: 28855300
[TBL] [Abstract][Full Text] [Related]
54. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.
Marshall AJ; Rattray M; Vaughan PF
Brain Res; 2006 Jul; 1099(1):18-24. PubMed ID: 16762326
[TBL] [Abstract][Full Text] [Related]
55. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP.
Fernandez JW; Rezai-Zadeh K; Obregon D; Tan J
FEBS Lett; 2010 Oct; 584(19):4259-67. PubMed ID: 20849853
[TBL] [Abstract][Full Text] [Related]
56. The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.
Delarasse C; Auger R; Gonnord P; Fontaine B; Kanellopoulos JM
J Biol Chem; 2011 Jan; 286(4):2596-606. PubMed ID: 21081501
[TBL] [Abstract][Full Text] [Related]
57. Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.
Yuksel M; Tacal O
Eur J Pharmacol; 2019 Aug; 856():172415. PubMed ID: 31132354
[TBL] [Abstract][Full Text] [Related]
58. Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production.
Tian Y; Crump CJ; Li YM
J Biol Chem; 2010 Oct; 285(42):32549-56. PubMed ID: 20675367
[TBL] [Abstract][Full Text] [Related]
59. ADAMs family members as amyloid precursor protein alpha-secretases.
Allinson TM; Parkin ET; Turner AJ; Hooper NM
J Neurosci Res; 2003 Nov; 74(3):342-52. PubMed ID: 14598310
[TBL] [Abstract][Full Text] [Related]
60. Conformational changes and disease--serpins, prions and Alzheimer's.
Carrell RW; Gooptu B
Curr Opin Struct Biol; 1998 Dec; 8(6):799-809. PubMed ID: 9914261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
